On the other hand, some researchers believe that tau protein is more relevant in dementia, and consequently suggest targeting tau protein may be a more meaningful approach than focusing on the development of anti-amyloid therapy in protecting corporeal action in Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.